Cargando…

Deoxycoformycin in the treatment of mature B-cell malignancies.

Detalles Bibliográficos
Autores principales:	Dearden, C., Catovsky, D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971740/ https://www.ncbi.nlm.nih.gov/pubmed/2390480

Ejemplares similares

Deoxycoformycin in the treatment of mature T-cell leukaemias.
por: Dearden, C., et al.
Publicado: (1991)

Preclinical Assessment of the Treatment of Second-Stage African Trypanosomiasis with Cordycepin and Deoxycoformycin
por: Vodnala, Suman K., et al.
Publicado: (2009)

Potentiation of Growth‐inhibitory Activity of 9‐β‐d‐Arabinofuranosyladenine by 2′‐Deoxycoformycin in Human Cultured Cell Lines Derived from Leukemias and Lymphomas
por: Kuroki, Yasumasa, et al.
Publicado: (1989)

Long-term follow-up after purine analogue therapy in hairy cell leukaemia
por: Else, Monica, et al.
Publicado: (2015)

Mature T-Cell leukemias: Challenges in Diagnosis
por: El-Sharkawi, Dima, et al.
Publicado: (2022)

Fludarabine phosphate for the treatment of low grade lymphoid malignancy.
por: Whelan, J. S., et al.
Publicado: (1991)

An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy
por: Sarid, Nadav, et al.
Publicado: (2015)

Proceedings: Methods for the study and cell differentiation in acute leukaemia.
por: Catovsky, D.
Publicado: (1975)

The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies
por: Arruga, Francesca, et al.
Publicado: (2018)

Role of Notch2 pathway in mature B cell malignancies
por: Mesini, Nicolò, et al.
Publicado: (2023)

A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia
por: Broccoli, Alessandro, et al.
Publicado: (2022)

Restoring Apoptosis with BH3 Mimetics in Mature B-Cell Malignancies
por: Jullien, Maxime, et al.
Publicado: (2020)

Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation
por: Di Bernardo, Maria Chiara, et al.
Publicado: (2012)

An integrated proteome and transcriptome of B cell maturation defines poised activation states of transitional and mature B cells
por: Salerno, Fiamma, et al.
Publicado: (2023)

Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells
por: Korniotis, Sarantis, et al.
Publicado: (2016)

Complement Activation in the Treatment of B-Cell Malignancies
por: Zent, Clive S., et al.
Publicado: (2020)

CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challenges
por: Narkhede, Mayur, et al.
Publicado: (2021)

Malignant Degeneration of a Mature Ovarian Teratoma
por: Mahtate, Mariam, et al.
Publicado: (2021)

Immunomodulatory Drugs for the Treatment of B Cell Malignancies
por: Ioannou, Nikolaos, et al.
Publicado: (2021)

Advances and Perspectives in the Treatment of B-Cell Malignancies
por: Cuenca, Marta, et al.
Publicado: (2021)

B-cell colony growth of malignant and normal B-cells.
por: Kluin-Nelemans, J. C., et al.
Publicado: (1987)

Risk factors for malignant transformation of mature cystic teratoma
por: Park, Chan-Hong, et al.
Publicado: (2015)

The long‐term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years
por: Else, Monica, et al.
Publicado: (2015)

Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells
por: Scheck, Adrienne C, et al.
Publicado: (2006)

Targeting histone deacetyalses in the treatment of B- and T-cell malignancies
por: Zain, Jasmine, et al.
Publicado: (2010)

A modular transcriptome map of mature B cell lymphomas
por: Loeffler-Wirth, Henry, et al.
Publicado: (2019)

Mature B cells and mesenchymal stem cells control emergency myelopoiesis
por: Lim, Vivian Y, et al.
Publicado: (2023)

Maturation-dependent expression of AIM2 in human B-cells
por: Svensson, Alexandra, et al.
Publicado: (2017)

Multiple malignant transformations of an ovarian mature cystic teratoma
por: Cagino, Kristen, et al.
Publicado: (2020)

Malignant transformation of a mature retroperitoneal teratoma into adenocarcinoma
por: Abdellaoui, M., et al.
Publicado: (2022)

Nivolumab for malignant transformation of ovarian mature cystic teratoma
por: Yoshimura, Kayoko, et al.
Publicado: (2022)

Two loci affecting B cell responses to B cell maturation factors
Publicado: (1986)

Targeting CD22 for the Treatment of B-Cell Malignancies
por: Shah, Nikesh N, et al.
Publicado: (2021)

Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis
por: Hainsworth, John D
Publicado: (2003)

Quantifying evolutionary constraints on B-cell affinity maturation
por: McCoy, Connor O., et al.
Publicado: (2015)

Germ cell development in the Honeybee (Apis mellifera); Vasa and Nanos expression
por: Dearden, Peter K
Publicado: (2006)

Maturation of Marginal Zone and Follicular B Cells Requires B Cell Activating Factor of the Tumor Necrosis Factor Family and Is Independent of B Cell Maturation Antigen
por: Schneider, Pascal, et al.
Publicado: (2001)

γδTFH cells promote B cell maturation and antibody production in neuroblastoma
por: Mou, Wenjun, et al.
Publicado: (2017)

Successful Treatment of Aggressive Mature B-cell Lymphoma Mimicking Immune Thrombocytopenic Purpura
por: Ono, Koya, et al.
Publicado: (2018)

B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages
por: Nobari, Shirin Teymouri, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fdd8kcgl6dcclgibc0ac574efe